MX2011007606A - Vacunas atenuadas vivas. - Google Patents

Vacunas atenuadas vivas.

Info

Publication number
MX2011007606A
MX2011007606A MX2011007606A MX2011007606A MX2011007606A MX 2011007606 A MX2011007606 A MX 2011007606A MX 2011007606 A MX2011007606 A MX 2011007606A MX 2011007606 A MX2011007606 A MX 2011007606A MX 2011007606 A MX2011007606 A MX 2011007606A
Authority
MX
Mexico
Prior art keywords
live attenuated
attenuated vaccines
attenuated
abc transporter
mutation
Prior art date
Application number
MX2011007606A
Other languages
English (en)
Inventor
Phillip Francis Markham
Chi-Wen Tseng
Glenn Francis Browning
Original Assignee
Australian Poultry Crc Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009900736A external-priority patent/AU2009900736A0/en
Application filed by Australian Poultry Crc Pty Ltd filed Critical Australian Poultry Crc Pty Ltd
Publication of MX2011007606A publication Critical patent/MX2011007606A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención, se relaciona con una bacteria atenuada mediante una mutación en al menos un gen transportador con ABC en donde la mutación hace que la proteína del transportador con ABC correspondiente no sea funcional y en donde la bacteria atenuada persiste en un sujeto.
MX2011007606A 2009-02-20 2010-02-17 Vacunas atenuadas vivas. MX2011007606A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2009900736A AU2009900736A0 (en) 2009-02-20 Live attenuated vaccines
PCT/AU2010/000172 WO2010094064A1 (en) 2009-02-20 2010-02-17 Live attenuated vaccines

Publications (1)

Publication Number Publication Date
MX2011007606A true MX2011007606A (es) 2011-08-08

Family

ID=42633348

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007606A MX2011007606A (es) 2009-02-20 2010-02-17 Vacunas atenuadas vivas.

Country Status (10)

Country Link
US (1) US20120045475A1 (es)
EP (1) EP2398892A4 (es)
JP (1) JP5753098B2 (es)
CN (1) CN102317439B (es)
AU (1) AU2010215065B2 (es)
BR (1) BRPI1008561A2 (es)
CA (1) CA2750136A1 (es)
MX (1) MX2011007606A (es)
RU (1) RU2556813C2 (es)
WO (1) WO2010094064A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2660000T3 (es) 2008-09-26 2018-03-20 Ambrx, Inc. Vacunas y microorganismos dependientes de la replicación de aminoácidos no naturales
CA2799732A1 (en) * 2010-05-19 2011-11-24 Bioproperties Pty Ltd Methods relating to an attenuated mycoplasma
WO2013091040A2 (pt) * 2011-12-22 2013-06-27 Universidade Federal De Minas Gerais - Ufmg Cepa atenuada de brucella ovis, composição vacinal e uso
US8734814B2 (en) 2012-03-02 2014-05-27 Asis Datta Recombinant microorganisms and uses thereof
AU2013280718B2 (en) * 2012-06-27 2016-06-09 Boehringer Ingelheim Animal Health USA Inc. Attenuated Streptococcus suis vaccines and methods of making and use thereof
LT3334454T (lt) * 2015-08-14 2022-12-27 Zoetis Services Llc Mycoplasma bovis kompozicijos
US10071149B2 (en) 2016-05-03 2018-09-11 Brigham Young University Temperature sensitive multivalent Bordetella avium vaccines
CN105999281B (zh) * 2016-07-26 2019-02-19 河南后羿生物工程股份有限公司 禽类活病毒用冻干保护剂、制备方法及应用
MX2018015344A (es) 2016-12-15 2019-04-29 Nestec Sa Composiciones y metodos que modulan las bacterias en un animal de compañía.
WO2018140717A1 (en) 2017-01-27 2018-08-02 University Of Florida Research Foundation Incorporated A food safety vaccine to control salmonella enterica and reduce campylobacter in poultry
CN107308445B (zh) * 2017-07-26 2020-11-24 山东省滨州畜牧兽医研究院 羊三联四防亚单位疫苗及其制备方法
US20200164055A1 (en) * 2017-07-31 2020-05-28 Kansas State University Research Foundation Vaccines against tick-borne diseases
CN108414751A (zh) * 2018-03-22 2018-08-17 山西省动物疫病预防控制中心 一种鸡白痢染色凝集抗原及其制备方法
CN108929864B (zh) * 2018-07-19 2021-03-23 浙江农林大学 用于预防鸡传染性法氏囊病的致弱病毒及用途
CN109758427B (zh) * 2019-02-26 2021-11-02 兆丰华生物科技(福州)有限公司 一种伪狂犬病活疫苗耐热保护剂及其制备方法和应用
CN117881785A (zh) * 2021-08-30 2024-04-12 天野酶制品株式会社 具有提高了的蛋白质生产率的微生物及其利用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000256A (en) * 1975-04-30 1976-12-28 Merck & Co., Inc. Varicella vaccine and process for its preparation
AU2001295795A1 (en) * 2000-10-26 2002-05-06 Imperial College Innovations Ltd. Streptococcal genes
JP4183504B2 (ja) * 2000-10-26 2008-11-19 インペリアル イノベーションズ リミテッド ストレプトコッカス遺伝子
GB0308691D0 (en) * 2003-04-07 2003-05-21 Xenova Res Ltd Vaccine preparations
WO2006089121A2 (en) * 2005-02-18 2006-08-24 Kent Seatech Corporation Streptococcus iniae phosphoglucomutase is a virulence factor and target for vaccine development
RU2468083C1 (ru) * 2011-04-25 2012-11-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") Способ получения l-аминокислоты с использованием бактерии семейства enterobacteriaceae, в которой ослаблена экспрессия генов, кодирующих транспортер лизина/аргинина/орнитина

Also Published As

Publication number Publication date
CN102317439B (zh) 2015-11-25
RU2556813C2 (ru) 2015-07-20
EP2398892A1 (en) 2011-12-28
AU2010215065B2 (en) 2014-05-15
CA2750136A1 (en) 2010-08-26
CN102317439A (zh) 2012-01-11
US20120045475A1 (en) 2012-02-23
EP2398892A4 (en) 2013-03-06
JP2012518388A (ja) 2012-08-16
RU2011138410A (ru) 2013-03-27
AU2010215065A1 (en) 2011-08-11
JP5753098B2 (ja) 2015-07-22
WO2010094064A1 (en) 2010-08-26
BRPI1008561A2 (pt) 2018-07-24

Similar Documents

Publication Publication Date Title
MX2011007606A (es) Vacunas atenuadas vivas.
AR083447A1 (es) Polipeptidos con actividad permeasa
PH12014501726A1 (en) Glyphosate resistant plants and associated methods
MX2011010040A (es) Sistema de limpieza que comprende una alfa-amilasa y una proteasa.
MX2014000989A (es) Composiciones detergentes.
MY169141A (en) Biodegradable compositions, methods and uses thereof
EP2569330A4 (en) CHLOROTOXINE VARIANTS, CONJUGATES, AND METHODS OF USE THEREOF
BRPI0919696A2 (pt) Polipeptídeo substancialmente purificado, microorganismo recombinante, e, polinucleotídeo isolado.
GB201000591D0 (en) Bacterial hoist strain
MY162837A (en) Modified relaxin polypeptides and their uses
HK1125315A1 (en) Recombinant attenuated clostridium organisms and vaccine
IN2012DN02073A (es)
IL220359A (en) Recombinant histolyticum collagenases and a method for their production
IN2012DN01604A (es)
AU2011347268A8 (en) Recombinant Mycobacterium as a vaccine
EA201291337A1 (ru) Огнеупорный блок и стекловаренная печь
DK2446019T3 (da) Rekombinant ethanologen bakterie
MX2011005281A (es) Vacuna marcadora de salmonella.
UA101158C2 (ru) ПЕПТИД RumC, КОТОРЫЙ ИМЕЕТ АНТИМИКРОБНУЮ АКТИВНОСТЬ
GB201309927D0 (en) Caspofungin analog, and preparation method and applications thereof
AR084605A1 (es) Cepa atenuada de brucella sp., composicion vacunal y uso
GB201106162D0 (en) Combination vaccine
NZ629535A (en) Bacterial vaccine
大门 et al. 83% WHITE 15% BLACK 2% RED
CL2009001549S1 (es) Sillon.

Legal Events

Date Code Title Description
FG Grant or registration